A. L. Beyler

866 total citations
33 papers, 629 citations indexed

About

A. L. Beyler is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, A. L. Beyler has authored 33 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in A. L. Beyler's work include Estrogen and related hormone effects (12 papers), Hormonal and reproductive studies (11 papers) and Steroid Chemistry and Biochemistry (6 papers). A. L. Beyler is often cited by papers focused on Estrogen and related hormone effects (12 papers), Hormonal and reproductive studies (11 papers) and Steroid Chemistry and Biochemistry (6 papers). A. L. Beyler collaborates with scholars based in United States. A. L. Beyler's co-authors include G. O. Potts, Aaron Arnold, R. O. Clinton, Clara M. Szego, A. J. Manson, F. W. Stonner, Frederick Coulston, H. Philip Schane, Hans P. Drobeck and James H. Ackerman and has published in prestigious journals such as Journal of the American Chemical Society, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

A. L. Beyler

32 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. L. Beyler United States	14	207	165	162	138	103	33	629
G. O. Potts United States	17	252 1.2×	187 1.1×	311 1.9×	317 2.3×	182 1.8×	47	978
P. K. Grover India	13	142 0.7×	78 0.5×	137 0.8×	87 0.6×	84 0.8×	33	514
M F Jayle France	18	378 1.8×	37 0.2×	255 1.6×	208 1.5×	102 1.0×	87	959
Stanley C. Lyster United States	14	123 0.6×	85 0.5×	85 0.5×	180 1.3×	41 0.4×	30	481
Janice M. Larner United States	16	195 0.9×	49 0.3×	221 1.4×	353 2.6×	69 0.7×	25	706
F. R. Mangan United Kingdom	12	215 1.0×	44 0.3×	239 1.5×	142 1.0×	57 0.6×	26	634
P. Scorza Barcellona Italy	14	226 1.1×	223 1.4×	49 0.3×	46 0.3×	169 1.6×	31	758
Hilton A. Salhanick United States	19	262 1.3×	53 0.3×	253 1.6×	316 2.3×	77 0.7×	53	935
J. O'Neal Johnston United States	15	314 1.5×	88 0.5×	164 1.0×	518 3.8×	82 0.8×	34	958
Marjorie C. Lindberg United States	12	227 1.1×	37 0.2×	105 0.6×	42 0.3×	29 0.3×	20	562

Countries citing papers authored by A. L. Beyler

Since Specialization

Citations

This map shows the geographic impact of A. L. Beyler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. L. Beyler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. L. Beyler more than expected).

Fields of papers citing papers by A. L. Beyler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. L. Beyler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. L. Beyler. The network helps show where A. L. Beyler may publish in the future.

Co-authorship network of co-authors of A. L. Beyler

This figure shows the co-authorship network connecting the top 25 collaborators of A. L. Beyler. A scholar is included among the top collaborators of A. L. Beyler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. L. Beyler. A. L. Beyler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arnold, Aaron, J.P. McAuliff, & A. L. Beyler. (1979). Metabolic Effects of a New Hypolipidemic Agent, Ciprofibrate. Journal of Pharmaceutical Sciences. 68(12). 1557–1558. 12 indexed citations

Ferrari, Richard A., et al.. (1978). Suppression of Sebaceous Gland Development in Laboratory Animals by 17α-Propyltestosterone. Journal of Investigative Dermatology. 71(5). 320–323. 17 indexed citations

Potts, G. O., A. L. Beyler, & H. Philip Schane. (1974). Pituitary Gonadotropin Inhibitory Activity of Danazol. Fertility and Sterility. 25(4). 367–372. 63 indexed citations

Beyler, A. L., Aaron Arnold, & G. O. Potts. (1968). Methods for evaluating anabolic and catabolic agents in laboratory animals.. PubMed. 23(8). 708–12. 1 indexed citations

Bell, Malcolm R., et al.. (1967). Isomeric Mannich Bases Derived from Ethyl 5-Hydroxy-2-methylindole-3-carboxylate. Journal of Medicinal Chemistry. 10(2). 264–266. 12 indexed citations

Tainter, M. L., et al.. (1964). ANABOLIC STEROIDS IN THE MANAGEMENT OF THE DIABETIC PATIENT.. PubMed. 64. 1001–9. 7 indexed citations

Arnold, Aaron, G. O. Potts, & A. L. Beyler. (1963). Evaluation of the Protein Anabolic Properties of Certain Orally Active Anabolic Agents Based on Nitrogen Balance Studies in Rats1. Endocrinology. 72(3). 408–417. 16 indexed citations

Manson, A. J., F. W. Stonner, Helmut Neumann, et al.. (1963). Steroidal Heterocycles. VII.¹ Androstano[2,3-d]isoxazoles and Related Compounds. Journal of Medicinal Chemistry. 6(1). 1–9. 79 indexed citations

Arnold, A., G. O. Potts, & A. L. Beyler. (1963). THE RATIO OF ANABOLIC TO ANDROGENIC ACTIVITY OF 7:17-DIMETHYLTESTOSTERONE, OXYMESTERONE, MESTANOLONE AND FLUOXYMESTERONE. Journal of Endocrinology. 28(1). 87–92. 4 indexed citations

10.

Arnold, Aaron, G. O. Potts, & A. L. Beyler. (1963). RELATIVE ORAL ANABOLIC TO ANDROGENIC ACTIVITY RATIOS OF ANDROISOXAZOLE, ETHYLESTRENOL, METHYLANDROSTENOLISOXAZOLE AND TESTOSTERONE. European Journal of Endocrinology. 44(4). 490–498. 9 indexed citations

11.

Beyler, A. L. & G. O. Potts. (1962). Influence of Gonadal and Adrenal Cortical Hormones on Estrogen-Induced Depletion of Pituitary Gonadotropin Content. Endocrinology. 70(5). 611–617. 5 indexed citations

12.

Beyler, A. L., G. O. Potts, & A. Arnold. (1961). INFLUENCE OF MOLECULAR UNSATURATION ON HORMONAL ACTIVITY PATTERN OF CERTAIN HETEROCYCLIC STEROIDS. Endocrinology. 68(6). 987–995. 6 indexed citations

13.

Beyler, A. L., G. O. Potts, Frederick Coulston, & Alexander R. Surrey. (1961). THE SELECTIVE TESTICULAR EFFECTS OF CERTAIN BIS-(DICHLOROACETYL) DIAMINES. Endocrinology. 69(4). 819–833. 38 indexed citations

14.

Coulston, Frederick, A. L. Beyler, & Hans P. Drobeck. (1960). The biologic actions of a new series of bis(dichloroacetyl) diamines. Toxicology and Applied Pharmacology. 2(6). 715–731. 43 indexed citations

15.

Potts, G. O., Aaron Arnold, & A. L. Beyler. (1960). COMPARATIVE MYOTROPHIC AND NITROGEN RETAINING EFFECTS OF SEVERAL STEROIDS¹. Endocrinology. 67(6). 849–854. 10 indexed citations

16.

Arnold, Aaron, A. L. Beyler, & G. O. Potts. (1959). Andro-stanazole, A New Orally Active Anabolic Steroid. Experimental Biology and Medicine. 102(1). 184–187. 16 indexed citations

17.

Clinton, R. O., A. J. Manson, F. W. Stonner, et al.. (1959). STEROIDAL [3,2-c]PYRAZOLES. Journal of the American Chemical Society. 81(6). 1513–1514. 92 indexed citations

18.

Beyler, A. L. & R. O. Clinton. (1956). Uterine Growth Stimulating and Testicular Growth Suppressing Activities of 17 -Ethinylandrostane-3 ,17 3-diol, Its -Analog and Derivatives.. Experimental Biology and Medicine. 92(2). 404–408. 2 indexed citations

19.

Beyler, A. L., et al.. (1956). THE BIOLOGICAL ACTIVITY OF A NEW DCA DERIVATIVE Δ¹,⁴-PREGNADIENE-21-OL-3;20-DIONE, 3-ACETATE. Endocrinology. 58(4). 471–476. 1 indexed citations

20.

Beyler, A. L. & Clara M. Szego. (1954). CORRELATION OF OVARIAN CHOLESTEROL LEVELS WITH CHANGES INβ-GLUCURONIDASE ACTIVITY OF REPRODUCTIVE TRACT DURING THE ESTROUS CYCLE AND PREGNANCY¹². Endocrinology. 54(3). 323–333. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact